LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Helmholtz Zentrum Muenchen GmbH
Headquarters:
Neuherberg, Germany
Website:
https://www.helmholtz-munic...
Year Founded:
1960
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Feb 27, 2025
Distillery Therapeutics
Inhibiting cathepsin B for pulmonary fibrosis
Read More
BioCentury
|
Mar 26, 2024
Distillery Therapeutics
Inhibiting inceptor for hyperglycemia in obesity
Read More
BioCentury
|
Feb 23, 2022
Deals
BioNTech adds to TCR arsenal with Medigene’s PRAME, platforms
The deal includes a switch technology that converts immunosuppressive ligands into costimulatory signals
Read More
BioCentury
|
Feb 11, 2022
Distillery Therapeutics
Phenotype-guided identification of small molecules for fibrosis
Read More
BioCentury
|
Dec 3, 2021
Discovery & Translation
Mapping the plasma proteome to identify drug targets; plus GSK-Vir, Codiak and more
BioCentury’s roundup of translational news
Read More
BioCentury
|
Dec 11, 2019
Emerging Company Profile
Flagship’s Cellarity maps out network-based drug discovery
Flagship launches Cellarity to deploy single cell technologies to find compounds that hit whole networks
Read More
BioCentury
|
Dec 11, 2019
Politics & Policy
Travel ban blocks team from receiving ASH accolades
Read More
BioCentury
|
Apr 30, 2019
Distillery Therapeutics
GP1BB identified as NASH target
Read More
BioCentury
|
Jan 11, 2019
Company News
Medigene licenses co-stimulator from Helmholtz to overcome checkpoint blockade with TCRs
Read More
BioCentury
|
Jan 23, 2018
Distillery Therapeutics
Endocrine / Metabolic
Read More
Items per page:
10
1 - 10 of 20
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help